About the Neoantigen Insights Hub
Get an insight into the kinds of people you could meet, why they want to attend and what makes this conference stand out.
Neoantigen Vaccine Development Interview with Anna-Dorothea Gorki, Chief Scientific Officer, YGION Biomedical
Gain expert insight into the future of neoantigen vaccine development in this exclusive interview with YGION’s Chief Scientific Officer, Anna-Dorothea Gorki. She shares her perspective on key challenges, emerging opportunities, and what’s driving innovation in cancer immunotherapy ahead of the International Neoantigen Summit.
Who Should Attend the International Neoantigen Summit?
From antigen discovery to clinical development, the neoantigen field requires alignment across teams. Explore which roles will gain the most value from attending the summit and how each function can accelerate progress.
Meet the Companies Leading Neoantigen Innovation
Connect with the companies shaping the future of neoantigen therapies. Discover who you can expect to meet and why this concentrated network of innovators matters for collaboration and progress.
Why the Neoantigen Community Comes Together
What makes this summit the focal point for the neoantigen community? Learn why experts across discovery, translational, and clinical teams come together to share data, solve challenges, and move the field forward.
Explore the Previous Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions